O. Dayan, B. C¸ etinkaya / Journal of Molecular Catalysis A: Chemical 271 (2007) 134–141
137
H 5.67; N 9.86%. IR (KBr; cm−1): 1576 (C N). H NMR (δ,
CDCl3): 1.27 [s, 36H, 4-C(Me)3Ph]; 2.75 [s, 6H, N C-Me]; 2.78
[s, 6H, N C-Me]; 6.88 [d, 4H, J = 8.4 Hz, Ph-Hm]; 6.94 [d, 4H,
J = 8.4 Hz, Ph-Hm]; 7.20 [d, 4H, J = 8.4 Hz, Ph-Ho]; 7.25 [d, 4H,
J = 8.8 Hz, Ph-Ho]; 7.58 [t, 2H, J = 8.0 Hz, Py-Hp]; 7.82 [d, 4H,
J = 8.8 Hz, Py-Hm]; 7.89 [s, 4H, Pyz-H]. 13C NMR (δ, CDCl3):
18.02; 31.55; 34.77; 122.26; 125.75; 128.44; 129.25; 146.02;
147.48; 149.97; 162.35; 170.61. IR (KBr; cm−1): 1576(C N).
was heated under reflux for 10 h. The resulting dark brown solu-
tion was cooled to room temperature and 4,4ꢀ-bipyridine (40 mg,
0.50 mmol) was added. The mixture was heated under reflux
for a further 2 h. The volatiles were removed under reduced
pressure and then the residue was dissolved in dichloromethane
(15 mL) and precipitated by addition of diethyl ether (30 mL).
The microcrystalline solid was filtered off and washed with
diethyl ether (3 × 10 mL) and pentane (3 × 10 mL). The desired
products were dried under reduced pressure at 50 ◦C for 1 h.
1
2.4.4. {(μ-Pyrazine)bis-[{2,6-bis[1-(2-methyl-4-N,N-
diethylaminophenylimino)ethyl]pyridine}
2.5.1. {(μ-4,4ˇı-Bipyridine)bis-[{2,6-bis[1-(4-N,N-
methylaminophenylimino)ethyl]pyridine} dichloro
dichlorodiruthenium(II)]} [Ru2(1d)2Cl4(C4H4N2)] (4d)
Yield: 940 mg, 68%. mp 355 ◦C (dec.). Anal. calcd. for
C66H86Cl4N12Ru2: C 56.97; H 6.23; N 12.08%; found: C 56.20;
diruthenium(II)]} [Ru2(1a)2Cl4(C10H8N2)] (5a)
Yield: 420 mg, 68%. mp 368 ◦C (dec.). Anal. calcd. for
C60H66Cl4N12Ru2: C 55.47; H 5.12; N 12.94%; found: C 55.12;
H 5.05; N 13.11%. 1H NMR (δ, CDCl3):): 2.77 [s, 12H, N C-
Me]; 2.84 [s, 24H, 4-NMe2-Ph]; 6.46 [d, 8H, J = 8.4 Hz, Ph-Hm];
6.90–6.93 [m, 12H, Ph-Ho, Bpy-Hm]; 7.54 [t, 2H, J = 7.8 Hz, Py-
Hp]; 7.81 [d, 4H, J = 8.4 Hz, Py-Hm]; 8.55 [d, 4H, J = 5.3 Hz,
Bpy-Ho]. 13C NMR (δ, CDCl3): 17.89; 40.98; 112.53; 123.70;
127.67;134.54;139.56;143.20;149.09;155.72;163.43;173.84.
IR (KBr; cm−1): 1609 (C N).
1
H 6.32; N 11.92%. H NMR (δ, CDCl3): 0.95–1.11 [m, 24H,
2-Me,4-N(CH2-Me)2-Ph]; 1.76–2.09 [m, 12H, 2-Me,4-N(CH2-
Me)2-Ph]; 2.65 [d, 12H, J = 5.6 Hz, N C-Me]; 2.97–3.31
[m, 16H, 2-Me,4-N(CH2-Me)2-Ph]; 6.06-6.18 [m, 4H, Ph-
Hm]; 6.27–6.34 [m, 4H, Ph-Hm]; 6.68–6.86 [m, 4H, Ph-Ho];
7.45–7.64 [m, 6H, Py-H]; 7.70–7.74 [m, 4H, Pyz-H]. 13C NMR
(δ, CDCl3): 12.77; 15.98; 18.31; 44.34; 109.63; 115.11; 117.64;
121.31;129.00;135.46;138.72;145.78;148.36;158.97;170.31.
IR (KBr; cm−1): 1583 (C N).
2.5.2. {(μ-4,4ˇı-Bipyridine)bis-[{2,6-bis[1-(2-methyl-4-
N,N-diethylaminophenylimino)ethyl] pyridine}
2.4.5. {(μ-Pyrazine)bis-[{2,6-bis[1-(2,4,6-
dichlorodiruthenium(II)]} [Ru2(1d)2Cl4(C10H8N2)] (5d)
Yield: 510 mg, 70%. mp 330 ◦C (dec.). Anal. calcd. for
C72H90Cl4N12Ru2: C 58.93 H 6.18; N 11.45%; found: C
trimethylphenylimino)ethyl]pyridine}dichloro
diruthenium(II)]} [Ru2(1e)2Cl4(C4H4N2)] (4e)
Yield 457 mg, 75%. mp 182 ◦C (dec.). Anal. calcd. for
C58H66Cl4N8Ru2: C 57.14; H 5.46; N 9.19%. found: C 56.78;
1
59.10; H 6.11; N 11.41%. H NMR (δ, CDCl3): 1.04 [t, 24H,
J = 6.6 Hz, 2-Me,4-N(CH2-Me)2-Ph]; 2.19 [s, 12H, 2-Me,4-
N(CH2-Me)2-Ph]; 2.73 [s, 12H, N C-Me]; 3.18–3.30 [m, 16H,
2-Me,4-N(CH2-Me)2-Ph]; 6.17 [d, 4H, J = 8.8 Hz, Ph-Ho]; 6.45
[s, 4H, Ph-Hm]; 6.86 [d, 4H, J = 6.4 Hz, Bpy-Hm]; 6.93 [t, 4H,
J = 8.2 Hz, Ph-Hm]; 7.59 [t, 2 H, J = 8.0 Hz, Py-Hp]; 7.84 [d, 4H,
J = 8.0, Py-Hm]; 8.55 [d, 4H, J = 4.8, Bpy-Ho]. 13C NMR (δ,
CDCl3): 12.63; 16.01; 18.34; 45.94; 110.56; 115.49; 118.67;
120.21; 121.72; 129.96; 136.54; 140.01; 144.32; 146.16;
155.22; 162.42; 172.12. IR (KBr; cm−1): 1600(C N).
1
H 6.32; N 10.18%. H NMR (δ, CDCl3): 2.01 [s, 24H, 2,6-
(Me)2 ,4-Me-Ph]; 2.13 [s, 12H, 2,6-(Me)2,4-Me-Ph]; 2.63 [s,
12H, N C-Me]; 6.59 [s, 8H, Ph-H]; 7.67 [t, 2H, J = 7.8 Hz,
Py-Hp]; 7.89 [d, 4H, J = 8.0 Hz, Py-Hm]; 8.24 [s, 4H, Pyz-H].
13C NMR (δ, CDCl3): 18.34; 20.54; 123.57; 128.51, 129.33,
131.36, 135.50; 144.60; 147.76; 162.26, 173.49. IR (KBr;
cm−1): 1635(C N).
2.4.6. {(μ-Pyrazine)bis-[{2,6-bis[1-(2-methyl-6-
ethylphenylimino)ethyl]pyridine}dichloro
2.5.3. {(μ-4,4ˇı-Bipyridine)bis-[{2,6-bis[1-(2,4,6-
diruthenium(II)]} [Ru2(1f)2Cl4(C4H4N2)] (4f)
trimethylphenylimino)ethyl]pyridine}
Yield 515 mg, 84%. mp 389 ◦C (dec.). Anal. calcd. for
C58H66Cl4N8Ru2: C 57.14; H 5.46; N 9.19%; found: C 57.88;
dichlorodiruthenium(II)]} [Ru2(1e)2Cl4(C10H8N2)] (5e)
Yield: 526 mg, 81%. mp 260 ◦C (dec.). Anal. calcd. for
C64H70Cl4N8Ru2: C 59.35; H 5.45; N 8.65%. found: C 59.87;
H 4.92; N 8.94%. 1H NMR (δ, CDCl3): 2.04 [s, 24H, 2,6-(Me)2
,4-Me-Ph]; 2.25 [s, 12H, 2,6-(Me)2,4-Me-Ph]; 2.68 [s, 12H,
N C-Me]; 6.76 [s, 8H, Ph-H]; 7.05 [d, 4H, J = 6.0, Bpy-Hm];
7.69 [t, 2H, J = 7.8 Hz, Py-Hp]; 7.93 [d, 4H, J = 8.0 Hz, Py-Hm];
8.52 [d, 4H, J = 6.0, Bpy-Ho]. 13C NMR (δ, CDCl3): 18.74;
20.92; 119.76; 123.70; 127.78; 129.42; 132.12; 135.36; 143.60;
144.63; 155.52; 162.97; 173.70. IR (KBr; cm−1): 1631(C N).
1
H 4.96; N 9.67%. H NMR (δ, CDCl3): 0.86–1.01 [m, 12H,
2-Me-6-(CH2-Me)-Ph]; 2.03–2.18 [m, 12H, 2-Me-6-(CH2-Me)-
Ph]; 2.53–2.69 [m, 16H, 2-Me-6-(CH2-Me)-Ph]; 2.63 [s, 12H,
N C-Me]; 6.76-6.95 [m, 12H, Ph-H]; 7.70 [t, 2H, J = 8.2 Hz,
Py-Hp]; 7.91 [d, 4H, J = 8.0 Hz, Py-Hm]; 8.24–8.30 [m, 4H, Pyz-
H]. 13C NMR (δ, CDCl3): 15.62; 18.83; 20.85; 25.14; 123.74,
126.65, 127.02;128.73;131.18;137.48;138.17;146.06;147.84;
162.35; 173.71. IR (KBr; cm−1): 1619(C N).
2.5. General procedure for the synthesis of Type 5
complexes
2.5.4. {(μ-4,4ˇı-Bipyridine)bis-[{2,6-bis[1-(2-methyl-6-
ethylphenylimino)ethyl]pyridine}
dichlorodiruthenium(II)]} [Ru2(1f)2Cl4(C10H8N2)] (5f)
Yield 503 mg, 78%. mp 370 ◦C (dec.). Anal. calcd. for
C64H70Cl4N8Ru2: C 59.35; H 5.45; N 8.65%; found: C 60.14;
An ethanolic solution (15 mL) of 1.10 eq. of 1 was mixed with
[RuCl2(p-cymene)]2 (306 mg, 0.50 mmol). Thereactionmixture